SpringWorks Therapeutics (SWTX) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
SWTX is expected to report earnings to fall 5.88% to -67 cents per share on March 04
Q4'24
Est.
$-0.68
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.58
Q1'24
Missed
by $0.01
Q4'23
Missed
by $0.20
The last earnings report on November 12 showed earnings per share of -72 cents, beating the estimate of -75 cents. With 2.09M shares outstanding, the current market capitalization sits at 2.71B.
a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer